Pender Fund Capital Management Ltd. Bausch Health Companies Inc. Transaction History

Pender Fund Capital Management Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$7.06 - $23.63 $1.35 Million - $4.51 Million	-190,925 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$21.6 - $27.79 $280,800 - $361,270	-13,000 Reduced 6.37%	190,925 $5.45 Million
Q4 2021 Feb 16, 2022	BUY	$23.0 - $29.01 $9,200 - $11,604	400 Added 0.2%	203,925 $7.13 Million
Q3 2021 Nov 15, 2021	SELL	$25.04 - $30.06 $30,048 - $36,072	-1,200 Reduced 0.59%	203,525 $7.19 Million
Q2 2021 Aug 13, 2021	SELL	$27.43 - $32.7 $1.59 Million - $1.89 Million	-57,900 Reduced 22.05%	204,725 $7.45 Million
Q1 2021 May 10, 2021	SELL	$21.37 - $34.38 $1.19 Million - $1.91 Million	-55,500 Reduced 17.45%	262,625 $10.5 Million
Q4 2020 Feb 12, 2021	SELL	$15.31 - $21.12 $15,310 - $21,120	-1,000 Reduced 0.31%	318,125 $8.4 Million
Q3 2020 Nov 16, 2020	BUY	$14.88 - $20.13 $4.75 Million - $6.42 Million	319,125 New	319,125 $6.38 Million

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.72B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Pender Fund Capital Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Pender Fund Capital Management Ltd. with notifications on news.